Company Innovus Pharmaceuticals Inc Other OTC
Equities
US45778V1061
Pharmaceuticals
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joshua Disbrow
CEO | Chief Executive Officer | 49 | - |
Chief Operating Officer | - | 18-05-31 | |
Steven Klayman
PRN | Corporate Officer/Principal | - | - |
Mostafa Abuzeid
PRN | Corporate Officer/Principal | - | - |
Hans Christinger
PRN | Corporate Officer/Principal | - | - |
Gilbert Jaoudé
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,204,401 | 2,483,540 ( 77.50 %) | 0 | 77.50 % |
Company contact information
Innovus Pharmaceuticals, Inc.
373 Inverness Parkway Suite 206
80112, Englewood
+858-964-5123
http://www.innovuspharma.comSector
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |